SEC Form 4 · accession 0001209191-15-015143
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward A. Neff
Director
Period of report
Feb 13, 2015
Accepted (ET)
Feb 18, 2015 · 2:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 13, 2015 | P | 40,000 | $1.25 | A | 187,386 | I | By corporation |
| Common Stock | holding | — | — | — | 4,178 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common StockF1 | $1.56 | Feb 13, 2015 | P | 40,000 | A | Feb 13, 2015 | Feb 13, 2020 | Common Stock | 40,000 | 40,000 | I |
Explanation of responses
- F1Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.25 per unit.